Condition
Atherosclerosis Cardiovascular Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Atherosclerosis Cardiovascular Disease clinical trials that are recruiting, at sites in 40 countries (most in Australia (2), China (2), Netherlands (2)). By phase: Phase 2 (2), Phase 4 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 40Countries
Newest Atherosclerosis Cardiovascular Disease clinical trials
All recruiting trials (10)
-
Understanding heart artery disease using biomarkers and imaging in Oxford
Researchers in Oxford are testing how biomarkers and advanced imaging can help explain why some heart artery plaques are unstable and how this affects heart damage after a heart attack.
-
Isometric resistance exercise for atherosclerosis in hypertension
This study tests whether isometric resistance exercise, like wall squats, can improve markers of atherosclerosis in adults with high blood pressure.
-
How moderate wine drinking affects healthy aging through post-meal extracellular vesicles
This test will see if a single serving of red or white wine changes circulating extracellular vesicles in healthy adults aged 35–65.
-
ABP-745 to reduce atherosclerotic plaque in people with ASCVD
This trial will test whether ABP-745 reduces atherosclerotic plaque over 52 weeks in adults (18–75) with ASCVD who are already taking oral lipid-lowering therapy.
-
Mouth bacteria and carotid artery plaque vulnerability
This project will see if mouth bacteria are linked to vulnerable carotid plaques in adults having carotid endarterectomy at Semmelweis University.
-
Association Between Severe Periodontitis and Arterial Stiffness: The PAROCAR Study
This study tests whether adults with generalized stage 3-4 periodontitis have greater arterial stiffness than healthy adults, to see if severe gum disease links to higher cardiovascular risk.
-
Orforglipron to lower cardiovascular events in adults with atherosclerotic cardiovascular disease or chronic kidney disease (ATTAIN-Outcomes)
This trial tests whether orforglipron reduces heart-related events compared with placebo in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease.
-
Monitoring coronary artery plaque progression in people with type 2 diabetes.
This project will follow adults with type 2 diabetes who already had a coronary CT angiography to see how plaque in their heart arteries changes over time.
-
PET/MRI with [18F]AlF-NOTA-octreotide to image inflammation in carotid artery plaque
This will test whether [18F]AlF-OC PET/MRI can measure inflammation in carotid plaques and help predict recurrent stroke or TIA in people who recently had a carotid-territory stroke or high-risk TIA with at least 30% carotid stenosis.
-
Effects of Tirzepatide on Heart Health in Overweight Individuals
This study tests if tirzepatide can improve heart health and reduce plaque in the arteries of overweight people with stable coronary artery disease.
Related topics
Quick answers
How many Atherosclerosis Cardiovascular Disease clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 40 countries. The most sites are in Australia (2 trials), China (2 trials), Netherlands (2 trials), France (2 trials), Belgium (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 4: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.